198 related articles for article (PubMed ID: 36452327)
1. Cocultivation of Chinese prescription and intestine microbiota: SJZD alleviated the major symptoms of IBS-D subjects by tuning neurotransmitter metabolism.
Xia X; Xie Y; Chen Q; Ding D; Wang Z; Xu Y; Wang Y; Wang X; Ding W
Front Endocrinol (Lausanne); 2022; 13():1053103. PubMed ID: 36452327
[TBL] [Abstract][Full Text] [Related]
2. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics integrated analyses indicated that non-polysaccharides of Sijunzi decoction ameliorated spleen deficiency syndrome via regulating microbiota-gut-metabolites axis and exerted synergistic compatibility.
Dong B; Peng Y; Wang M; Peng C; Li X
J Ethnopharmacol; 2024 Sep; 331():118276. PubMed ID: 38697408
[TBL] [Abstract][Full Text] [Related]
4. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
5. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
[TBL] [Abstract][Full Text] [Related]
6. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
[TBL] [Abstract][Full Text] [Related]
7. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
[TBL] [Abstract][Full Text] [Related]
8. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
[TBL] [Abstract][Full Text] [Related]
9. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
[TBL] [Abstract][Full Text] [Related]
10. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
11. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
[TBL] [Abstract][Full Text] [Related]
12. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
[TBL] [Abstract][Full Text] [Related]
13. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Carroll IM; Ringel-Kulka T; Siddle JP; Ringel Y
Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879
[TBL] [Abstract][Full Text] [Related]
14. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
15. Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome.
Hou Y; Dong L; Lu X; Shi H; Xu B; Zhong W; Ma L; Wang S; Yang C; He X; Zhao Y; Wang S
Dig Dis Sci; 2022 Dec; 67(12):5580-5592. PubMed ID: 35879512
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-Associated Microbiota in Patients with Irritable Bowel Syndrome: A Comparison of Subtypes.
Matsumoto H; Shiotani A; Katsumata R; Fukushima S; Handa Y; Osawa M; Murao T; Handa O; Umegaki E; Inoue R; Naito Y
Digestion; 2021; 102(1):49-56. PubMed ID: 33271532
[TBL] [Abstract][Full Text] [Related]
17. A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D).
Ouyang L; Liu T; He Y; He Y; Xu W; Deng G; Deng G; Xiao X
J Ethnopharmacol; 2024 Jun; 328():118050. PubMed ID: 38518966
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
[TBL] [Abstract][Full Text] [Related]
19. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome.
Tang SQ; Wang YL; Xie ZY; Zhang Y; Guo Y; Gao KL; Mao TY; Xie CE; Li JX; Gao XY
J Integr Med; 2021 May; 19(3):274-281. PubMed ID: 33775600
[TBL] [Abstract][Full Text] [Related]
20. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
[No Abstract] [Full Text] [Related]
[Next] [New Search]
